PUBLISHER: The Business Research Company | PRODUCT CODE: 1942787
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942787
Electrocardiogram (ECG) telemetry devices remotely monitor and record the electrical activity of the heart over time. They are essential for diagnosing and managing heart rhythm problems, heart attacks, and other cardiac disorders by providing continuous, real-time cardiac information.
The main product categories of electrocardiogram (ECG) telemetry devices include event monitoring and mobile cardiac telemetry devices, implantable loop recorders, and others. Event monitoring and mobile cardiac telemetry devices are designed to record the heart's electrical signals over a defined time period, particularly during symptomatic events such as palpitations or dizziness. These devices are used for applications including arrhythmias, myocardial ischemia and infarction, and pacemaker monitoring, and are utilized by end users such as hospitals and home healthcare providers.
Tariffs have influenced the ECG telemetry devices market by increasing costs for imported electronic components, wireless modules, and miniaturized sensors. Segments like implantable loop recorders and wearable patch-based ECG devices are most affected, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. This has led to higher production costs and supply chain challenges. On the positive side, tariffs have encouraged local manufacturing, investment in domestic R&D, and innovation in cost-efficient ECG telemetry solutions.
The electrocardiogram (ecg) telemetry devices market research report is one of a series of new reports from The Business Research Company that provides electrocardiogram (ecg) telemetry devices market statistics, including electrocardiogram (ecg) telemetry devices industry global market size, regional shares, competitors with a electrocardiogram (ecg) telemetry devices market share, detailed electrocardiogram (ecg) telemetry devices market segments, market trends and opportunities, and any further data you may need to thrive in the electrocardiogram (ecg) telemetry devices industry. This electrocardiogram (ecg) telemetry devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electrocardiogram (ecg) telemetry devices market size has grown strongly in recent years. It will grow from $4.5 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to limited access to remote monitoring technologies, reliance on hospital-based ECG monitoring, growing prevalence of cardiovascular diseases, expansion of outpatient care, increasing awareness of arrhythmia management.
The electrocardiogram (ecg) telemetry devices market size is expected to see strong growth in the next few years. It will grow to $6.72 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to advancement in wireless mobile cardiac telemetry, adoption of miniaturized implantable loop recorders, increasing integration of AI and predictive analytics, growth of home healthcare services, expansion of cloud-enabled ECG monitoring platforms. Major trends in the forecast period include rising adoption of remote cardiac monitoring solutions, integration of cloud-based ecg data management, growing demand for home healthcare cardiac telemetry, increased use of wearable and patch-based ecg devices, focus on early detection and management of cardiovascular disorders.
The rising burden of cardiovascular diseases is increasingly supporting the expansion of the electrocardiogram (ECG) telemetry devices market going forward. Cardiovascular diseases (CVDs) include a group of disorders that affect the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The growing burden of cardiovascular diseases can be linked to unhealthy dietary patterns, lack of physical activity, tobacco consumption, excessive alcohol intake, air pollution, and socioeconomic factors including stress and poverty. ECG telemetry devices strengthen cardiovascular care by enabling continuous and real-time monitoring, facilitating remote and home-based care, improving the performance of implantable devices, supporting accurate diagnosis and personalized treatment, and enabling timely emergency interventions. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. As a result, the rising burden of cardiovascular diseases is significantly contributing to the expansion of the electrocardiogram (ECG) telemetry devices market.
Leading companies operating in the electrocardiogram (ECG) telemetry devices market are developing innovative solutions, such as AI-powered ECG systems, to improve diagnostic accuracy, enable real-time monitoring, and enhance overall cardiovascular care. AI-powered ECG systems integrate traditional electrocardiography with artificial intelligence algorithms to support advanced detection and interpretation of cardiac activity. For example, in July 2025, AliveCor Inc., a US-based mobile ECG technology provider, launched the Kardia 12L, an AI-enabled 12-lead ECG system for clinical and remote use. The device features a portable design with wireless connectivity, enabling rapid acquisition of 12-lead ECGs. AI-driven analytics detect arrhythmias, myocardial infarction risk, and other abnormalities while providing real-time reports and seamless integration with electronic health records and telehealth platforms.
In May 2024, WearLinq Inc., a US-based provider of wearable health monitoring solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. With this acquisition, WearLinq aims to broaden access to its FDA 510(k)-cleared eWave 6-lead ECG monitor and expand its nationwide ambulatory cardiac monitoring capabilities. AMI Cardiac Monitoring LLC is a US-based provider of cardiac monitoring devices and related services.
Major companies operating in the electrocardiogram (ecg) telemetry devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., General Electric Company, Boston Scientific Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH, Biotronik SE & Co KG, Japan Lifeline Co Ltd, CardioFocus Inc, CathRx Ltd, Baylis Medical Company Inc, Ablacon Inc, Adagio Medical Inc, VytronUS Inc.
North America was the largest region in the electrocardiogram (ECG) telemetry devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrocardiogram (ecg) telemetry devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electrocardiogram (ecg) telemetry devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The electrocardiogram (ECG) telemetry devices market consists of sales of ECG devices, stress ECG devices, holter monitors, event monitoring systems, and ECG management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electrocardiogram (ECG) Telemetry Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses electrocardiogram (ecg) telemetry devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electrocardiogram (ecg) telemetry devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrocardiogram (ecg) telemetry devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.